Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$24.97 - $34.05 $323,311 - $440,879
12,948 Added 35.09%
49,843 $1.28 Million
Q4 2022

Feb 13, 2023

SELL
$21.73 - $28.72 $140,810 - $186,105
-6,480 Reduced 14.94%
36,895 $959,000
Q3 2022

Nov 14, 2022

SELL
$24.1 - $39.66 $1.08 Million - $1.78 Million
-44,972 Reduced 50.9%
43,375 $1.24 Million
Q2 2022

Aug 11, 2022

BUY
$18.36 - $60.07 $1.62 Million - $5.31 Million
88,347 New
88,347 $2.18 Million
Q4 2020

Feb 11, 2021

SELL
$48.36 - $77.92 $351,770 - $566,790
-7,274 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$36.14 - $51.99 $262,882 - $378,175
7,274 New
7,274 $347,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.